The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Donald Trump took a moment from discussing his much-hyped plans to lower medication costs for Americans to talk about how ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

A doctor has issued a warning about a less documented side effect of Ozempic that can apparently have a long-term health ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

The first head-to-head trial of Mounjaro and Wegovy, the weight-loss drugs, compared the effectiveness of the two leading ...

TWO blockbuster weight loss just have been tested against each other for the first time in a head-to-head trial. There was a clear winner, which saw slimmers shed 20 per cent of their body weight.